Muromachi Chemicals Inc. plans, produces, and distributes pharmaceuticals and health foods in Japan. It offers active pharmaceutical ingredients and intermediate synthesis products; commissioned processing services for pharmaceuticals; and commissioned synthesis services for radioactive and stable isotope tagged compounds used in pharmaceutical and agricultural metabolic testing, as well as imports and sells active pharmaceutical ingredients. The company also provides jelly and non-alcoholic beverage products. In addition, it offers ion-exchange resins, separation membranes, and ion-exchange fibers; and solutions that meet customers' needs with water-treatment products, including filter media, equipment, and chemicals, as well as commissioned chemical processing services. Further, the company provides functional adhesives; and product contamination removal and dust removal mats, and antistatic products for use in the electronics industry, as well as engages in the commissioned manufacturing and processing of functional pastes. The company was founded in 1917 and is headquartered in Omuta, Japan.
Stock data | 2023 | Change |
---|---|---|
Price | $5.19 | N/A |
Market Cap | $19.60M | N/A |
Shares Outstanding | 3.77M | 2.35% |
Employees | 0 | N/A |
Shareholder Equity | 1.92B | 13.93% |
Valuation | 2023 | Change |
---|---|---|
P/E Ratio | 0.08 | N/A |
P/S Ratio | 0.44 | N/A |
P/B Ratio | 0.01 | N/A |
Growth | 2023 | Change |
---|---|---|
Return on Equity | 0.0009 | N/A |
Earnings | 2023 | Change |
---|---|---|
Revenue | $44.10M | N/A |
Earnings | $1.80M | N/A |
EPS | 64.12 | N/A |
Earnings Yield | 12.34 | N/A |
Gross Margin | 0.2785 | N/A |
Operating Margin | 0.0587 | N/A |
Net income margin | 0.0407 | N/A |
Financial Strength | 2023 | Change |
---|---|---|
Total Assets | $34.69M | N/A |
Total Debt | $11.00M | N/A |
Cash on Hand | $5.98M | N/A |
Debt to Equity | 0.0111 | -14.59% |
Cash to Debt | 0.5432 | 5.95% |
Current Ratio | $1.74 | 10.97% |